EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Curative hematopoietic stem cell transplantation in a child with specific granule deficiency due to a homozygous SMARCD2 variant

Janaki Menon, Revathi Raj, Shiny Padinjarayil Manakkad, Athulya Edavazhippurath, Priya Saravanan, Anjit Unnikrishnan, Ramya Uppuluri, Sheena Othayoth Kandy, Shammy Saphia, Kalpana George, Dhananjayan Dhanasooraj, Geeta Madathil Govindaraj

Pediatric Hematology Oncology Journal · 2024-12 · 9 (4) · 311-314

DOI: 10.1016/j.phoj.2024.11.103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Hematology Oncology Journal, 2024-12. Verfasst von Janaki Menon und 11 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Health Research, India.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Children with recurrent, severe infections that respond poorly to treatment are likely to have an underlying inborn error of immunity . Case Report A three-year-old male child of non-consanguineous parentage presented with recurrent severe infections from the neonatal period , including abscesses, pneumonia, diarrhea, meningitis, cystitis , and pyelonephritis . The child had subtle dysmorphic features . The dihydro rhodamine assay was abnormal, and the peripheral smear showed hypogranular, hypolobated neutrophils . Clinical exome sequencing revealed a homozygous variant in the SMARCD2 gene, confirming the diagnosis of specific granule deficiency 2. The child underwent a haploidentical hematopoietic transplant and is asymptomatic five months post-transplant. Conditioning chemotherapy included rabbit anti-thymocyte globulin/treosulphan/thiotepa/fludarabine. The CD34 dose infused was 15 x 10 6 /kilogram recipient body weight . The infused product was TCR alpha/beta and CD19 depleted with preserved TCR gamma/delta cells.

Conclusion

This case demonstrates that although ultra-rare inborn errors of immunity are often diagnosed by next-generation sequencing, simple hematological and immunological tests provide valuable clues. Timely hematopoietic stem cell transplantation is curative.

Förderung

  • Department of Health Research, India

Zitieren

APA

Menon, J., Raj, R., Manakkad, S. P., Edavazhippurath, A., Saravanan, P., Unnikrishnan, A., Uppuluri, R., Kandy, S. O., Saphia, S., George, K., Dhanasooraj, D., & Govindaraj, G. M. (2024). Curative hematopoietic stem cell transplantation in a child with specific granule deficiency due to a homozygous SMARCD2 variant. Pediatric Hematology Oncology Journal, 9(4), 311-314. https://doi.org/10.1016/j.phoj.2024.11.103

Vancouver

Menon J, Raj R, Manakkad SP, Edavazhippurath A, Saravanan P, Unnikrishnan A, et al. Curative hematopoietic stem cell transplantation in a child with specific granule deficiency due to a homozygous SMARCD2 variant. Pediatric Hematology Oncology Journal. 2024;9(4):311-314. doi:10.1016/j.phoj.2024.11.103

BibTeX
@article{Menon2024,
  author = {Menon, Janaki and Raj, Revathi and Manakkad, Shiny Padinjarayil and Edavazhippurath, Athulya and Saravanan, Priya and Unnikrishnan, Anjit and Uppuluri, Ramya and Kandy, Sheena Othayoth and Saphia, Shammy and George, Kalpana and Dhanasooraj, Dhananjayan and Govindaraj, Geeta Madathil},
  title = {Curative hematopoietic stem cell transplantation in a child with specific granule deficiency due to a homozygous SMARCD2 variant},
  journal = {Pediatric Hematology Oncology Journal},
  year = {2024},
  volume = {9},
  number = {4},
  pages = {311--314},
  doi = {10.1016/j.phoj.2024.11.103}
}
Kostenlos starten →